|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2008-11-26
|
|
pubmed:abstractText |
Left ventricular hypertrophy (LVH) and diastolic dysfunction occur after cardiac transplantation. We investigated sirolimus (SRL) as primary immunosuppression for the attenuation of LVH and diastolic dysfunction of the cardiac allograft.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1534-6080
|
|
pubmed:author |
pubmed-author:ChandrasekaranKrishnaswamyK,
pubmed-author:ClavellAlfredo LAL,
pubmed-author:DalyRichard CRC,
pubmed-author:EdwardsBrooks SBS,
pubmed-author:FrantzRobert PRP,
pubmed-author:KremersWalter KWK,
pubmed-author:KushwahaSudhir SSS,
pubmed-author:McGregorChristopher G ACG,
pubmed-author:PereiraNaveen LNL,
pubmed-author:RaichlinEugeniaE,
pubmed-author:RodehefferRichard JRJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
27
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1395-400
|
|
pubmed:meshHeading |
pubmed-meshheading:19034009-Adult,
pubmed-meshheading:19034009-Aged,
pubmed-meshheading:19034009-Calcineurin,
pubmed-meshheading:19034009-Cardiomyopathies,
pubmed-meshheading:19034009-Diastole,
pubmed-meshheading:19034009-Echocardiography,
pubmed-meshheading:19034009-Female,
pubmed-meshheading:19034009-Follow-Up Studies,
pubmed-meshheading:19034009-Heart Diseases,
pubmed-meshheading:19034009-Heart Transplantation,
pubmed-meshheading:19034009-Hemodynamics,
pubmed-meshheading:19034009-Humans,
pubmed-meshheading:19034009-Immunosuppressive Agents,
pubmed-meshheading:19034009-Male,
pubmed-meshheading:19034009-Middle Aged,
pubmed-meshheading:19034009-Sirolimus,
pubmed-meshheading:19034009-Systole,
pubmed-meshheading:19034009-Transplantation, Homologous,
pubmed-meshheading:19034009-Ventricular Dysfunction, Left,
pubmed-meshheading:19034009-Ventricular Function, Left
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft.
|
|
pubmed:affiliation |
Division of Cardiovascular Diseases and the William J. von Liebig Transplant Center, Mayo Clinic, Rochester, MN 55905, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
